Ipca Laboratories Ltd.

US generics players Bayshore Pharmaceuticals and Unichem Pharmaceuticals USA could soon be combined into a single US generic formulations player, under plans unveiled by Bayshore owner and Unichem maj

While India has played a salutary role in lowering cost of medicines across the world with generics, it’s time to move on to the next stage of development and that will require an easing of clinical d

Ipca Laboratories has entered into a technology transfer agreement with fellow Indian firm Omexa Formulary, granting Omexa non-exclusive rights to research, develop, manufacture and market an oncolog

At the midway point of 2023, dealmaking for big pharma had roared back to life following relative austerity in the previous two years, as credit became harder to come by, interest rates spiked, and le